HIGHLIGHTS
- who: Juan De los Santos-Jimu00e9nez et al. from the Canceromics Laboratory, Departamento Biologu00eda Molecular y Bioquu00edmica, Universidad Mu00e1laga, Mu00e1laga, Spain have published the research work: Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines, in the Journal: Cancers 2023, 531 of /2023/
- what: Studies focusing on potential compensatory pathways, and changes in methylation for both nucleotides and amino_acids, might also empower the development of new targeted combination therapies 19 of 21 research focusing on these and other Gln-related issues needs an in-depth exploration and analysis to be developed and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.